Page last updated: 2024-11-12
aplyronine a
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
aplyronine A: depolymerizes actin; potent antitumor cpd from the sea hare Aplysia kurodai; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 11840920 |
SCHEMBL ID | 2831675 |
MeSH ID | M0271899 |
Synonyms (8)
Synonym |
---|
aplyronine a |
DB04629 |
SCHEMBL2831675 |
hyl)amino]-2-hydroxy-1,3,7,9-tetramethylundec-10-enyl}-10-hydroxy-14,20-dimethoxy-9,11,15,18-tetramethyl-2-oxooxacyclote |
(8r,9r,10r,11r,14s,18s,20s,24s)-24-{(1r,2s,3r,6r,7r,8r,9s,10e)-8-(acetyloxy)-6-[(n,n-dimethylalanyl)oxy]-11-[formyl(met |
tracosa-3,5,15,21-tetraen-8-yl n,n,o-trimethylserinate |
(3e,5e,8r,9s,10r,11r,14s,15e,18r,20r,21e,24s)-24-{(1s,2s,3s,6r,7s,8r,9r,10e)-8-(acetyloxy)-6-[(n,n-dimethyl-l-alanyl)oxy]-11-[formyl(methyl)amino]-2-hydroxy-1,3,7,9-tetramethylundec-10-en-1-yl}-10-hydroxy-14,20-dimethoxy-9,11,15,18-tetramethyl-2-oxooxacyc |
Q27095366 |
Research Excerpts
Overview
Aplyronine A (ApA) is a marine natural product that shows potent antitumor activity. ApA is a macrolide isolated from Aplysia kurodai.
Excerpt | Reference | Relevance |
---|---|---|
"Aplyronine A (ApA) is a marine natural product that shows potent antitumor activity. " | ( Inhibition of microtubule assembly by a complex of actin and antitumor macrolide aplyronine A. Chinen, T; Hirayama, Y; Kigoshi, H; Kita, M; Sumiya, E; Uesugi, M; Usui, T; Yamagishi, K; Yoneda, K, 2013) | 2.06 |
"Aplyronine A is a macrolide isolated from Aplysia kurodai. " | ( Novel actin depolymerizing macrolide aplyronine A. Fusetani, N; Karaki, H; Kigoshi, H; Ozaki, H; Saito, S; Watabe, S; Yamada, K, 1996) | 2.01 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (26)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (3.85) | 18.2507 |
2000's | 7 (26.92) | 29.6817 |
2010's | 15 (57.69) | 24.3611 |
2020's | 3 (11.54) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 11.74
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.74) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 2 (7.41%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 25 (92.59%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |